General Patient Characteristics.
General Patient Characteristics.
| Characteristics | IVC Filter Group
n=93 |
Anticoagulation Group
n=1649 |
P Value |
|---|---|---|---|
| Age (y), mean±SD | 65.2±17.2 | 62.7±22.6 | 0.2 |
| Female gender, n (%) | 45 (48.4) | 969 (58.8) | 0.048 |
| History of myocardial infarction, n (%) | 14 (15.1) | 328 (19.9) | 0.3 |
| Chronic heart failure, n (%) | 6 (6.5) | 211 (12.8) | 0.07 |
| Peripheral vascular disease, n (%) | 9 (9.7) | 301 (18.3) | 0.035 |
| Dementia, n (%) | 11 (11.8) | 214 (13.0) | 0.7 |
| Chronic obstructive lung disease, n (%) | 4 (4.3) | 170 (10.3) | 0.06 |
| Connective tissue disease, n (%) | 5 (5.4) | 52 (3.2) | 0.2 |
| History of stroke, n (%) | 19 (20.4) | 218 (13.2) | 0.048 |
| Liver cirrhosis, n (%) | 2 (2.2) | 48 (2.9) | 0.7 |
| Chronic renal failure, n (%) | 34 (36.6) | 559 (33.9) | 0.6 |
| Diabetes mellitus, n (%) | 23 (24.7) | 453 (27.5) | 0.6 |
| Solid tumor, n (%) | 41 (44.1) | 403 (24.4) | <0.001 |
| Leukemia, n (%) | 1 (1.1) | 13 (0.8) | 0.5 |
| Lymphoma, n (%) | 4 (4.3) | 44 (2.7) | 0.3 |
| Metastatic tumor, n (%) | 26 (28.0) | 189 (11.5) | <0.001 |
| Charlson score, median (IQR) | 4 (2; 8) | 3 (0; 6) | <0.001 |